149 related articles for article (PubMed ID: 38302400)
21. Characterization of a new
Whiteley LE; Whiteley M
Microbiol Spectr; 2024 Mar; 12(3):e0371923. PubMed ID: 38345389
[TBL] [Abstract][Full Text] [Related]
22. Metabolic Mechanism and Physiological Role of Glycerol 3-Phosphate in Pseudomonas aeruginosa PAO1.
Liu Y; Sun W; Ma L; Xu R; Yang C; Xu P; Ma C; Gao C
mBio; 2022 Dec; 13(6):e0262422. PubMed ID: 36218368
[TBL] [Abstract][Full Text] [Related]
23. IL-17A impairs host tolerance during airway chronic infection by Pseudomonas aeruginosa.
Lorè NI; Cigana C; Riva C; De Fino I; Nonis A; Spagnuolo L; Sipione B; Cariani L; Girelli D; Rossi G; Basso V; Colombo C; Mondino A; Bragonzi A
Sci Rep; 2016 May; 6():25937. PubMed ID: 27189736
[TBL] [Abstract][Full Text] [Related]
24. Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa.
Cachia PJ; Hodges RS
Biopolymers; 2003; 71(2):141-68. PubMed ID: 12767116
[TBL] [Abstract][Full Text] [Related]
25.
Verstraete L; Aizawa J; Govaerts M; De Vooght L; Lavigne R; Michiels J; Van den Bergh B; Cos P
Microbiol Spectr; 2023 Jun; 11(3):e0497022. PubMed ID: 37140371
[TBL] [Abstract][Full Text] [Related]
26. Environmental Pseudomonads Inhibit Cystic Fibrosis Patient-Derived Pseudomonas aeruginosa.
Chatterjee P; Davis E; Yu F; James S; Wildschutte JH; Wiegmann DD; Sherman DH; McKay RM; LiPuma JJ; Wildschutte H
Appl Environ Microbiol; 2017 Jan; 83(2):. PubMed ID: 27881418
[TBL] [Abstract][Full Text] [Related]
27. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.
Hogardt M; Heesemann J
Curr Top Microbiol Immunol; 2013; 358():91-118. PubMed ID: 22311171
[TBL] [Abstract][Full Text] [Related]
28. Piceatannol modulates lung epithelial cellular responses to Pseudomonas aeruginosa.
Aval PS; Werner J; Cerqueira A; Balfour-Boehm J; Ulanova M
Inflamm Allergy Drug Targets; 2013 Oct; 12(5):297-307. PubMed ID: 23713607
[TBL] [Abstract][Full Text] [Related]
29. [Pseudomonas aeruginosa as the pathogen in opportunistic infections].
Dalhoff A
Infection; 1987; 15(1):69-72. PubMed ID: 3106231
[TBL] [Abstract][Full Text] [Related]
30. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane.
Sabnis A; Hagart KL; Klöckner A; Becce M; Evans LE; Furniss RCD; Mavridou DA; Murphy R; Stevens MM; Davies JC; Larrouy-Maumus GJ; Clarke TB; Edwards AM
Elife; 2021 Apr; 10():. PubMed ID: 33821795
[TBL] [Abstract][Full Text] [Related]
31. The Effects of Antibiotic Combination Treatments on Pseudomonas aeruginosa Tolerance Evolution and Coexistence with Stenotrophomonas maltophilia.
Law JP; Wood AJ; Friman VP
Microbiol Spectr; 2022 Dec; 10(6):e0184222. PubMed ID: 36453898
[TBL] [Abstract][Full Text] [Related]
32. Ketone bodies in cell physiology and cancer.
Giuliani G; Longo VD
Am J Physiol Cell Physiol; 2024 Mar; 326(3):C948-C963. PubMed ID: 38189128
[TBL] [Abstract][Full Text] [Related]
33. Role of Host and Bacterial Lipids in
Constantino-Teles P; Jouault A; Touqui L; Saliba AM
Front Immunol; 2022; 13():931027. PubMed ID: 35860265
[TBL] [Abstract][Full Text] [Related]
34. The genetic basis for the commitment to chronic versus acute infection in Pseudomonas aeruginosa.
Yahr TL; Greenberg EP
Mol Cell; 2004 Nov; 16(4):497-8. PubMed ID: 15546607
[TBL] [Abstract][Full Text] [Related]
35. Association of Circulating Ketone Bodies With Functional Outcomes After ST-Segment Elevation Myocardial Infarction.
de Koning MLY; Westenbrink BD; Assa S; Garcia E; Connelly MA; van Veldhuisen DJ; Dullaart RPF; Lipsic E; van der Harst P
J Am Coll Cardiol; 2021 Oct; 78(14):1421-1432. PubMed ID: 34593124
[TBL] [Abstract][Full Text] [Related]
36. The Pseudomonas aeruginosa opportunistic pathogen and human infections.
de Bentzmann S; Plésiat P
Environ Microbiol; 2011 Jul; 13(7):1655-65. PubMed ID: 21450006
[TBL] [Abstract][Full Text] [Related]
37. [Chinese expert consensus on the management of lower respiratory tract infections of
Pulmonary Infection Assembly of Chinese Thoracic Society
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Aug; 45(8):739-752. PubMed ID: 35927044
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and resistance of Pseudomonas aeruginosa in severely burned patients: a 10-year retrospective study.
Lipový B; Rihová H; Hanslianová M; Gregorová N; Suchánek I; Brychta P
Acta Chir Plast; 2010; 52(2-4):39-43. PubMed ID: 21749009
[TBL] [Abstract][Full Text] [Related]
39. Subversion of the Complement System by Pseudomonas aeruginosa.
Hastings CJ; Syed SS; Marques CNH
J Bacteriol; 2023 Aug; 205(8):e0001823. PubMed ID: 37436150
[TBL] [Abstract][Full Text] [Related]
40. Inflammation: A Double-Edged Sword in the Response to Pseudomonas aeruginosa Infection.
Lin CK; Kazmierczak BI
J Innate Immun; 2017; 9(3):250-261. PubMed ID: 28222444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
